Status
Conditions
Treatments
About
The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.
Full description
After being informed about the study and potential risks, all patients giving written informed consent will undergo screening to determine eligibility for study entry. Participants who meet eligibility requirements will be randomized in a double blind manner (participant and investigator) to each treatment arm depending on their primary complaint. Participants with erectile dysfunction will be randomized 2:2:1 to either fSWT, rWT or sham therapy. Patients with chronic pelvic pain syndrome will be randomized 1:1 to either fSWT with pelvic floor physical therapy (PFPT) or PFPT with sham treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following)
Exclusion Criteria (ED):
Chronic Pelvic Pain Syndrome Group:
Inclusion Criteria (CPPS): (all of the following)
Exclusion criteria (CPPS):
Primary purpose
Allocation
Interventional model
Masking
186 participants in 3 patient groups
Loading...
Central trial contact
Petar Bajic
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal